Influence of nutrition on liver oxidative metabolism

Nutrition

Volumn 12, Issue 6, 1996, Pages 442-447

  Jorquera, Francisco ^a   Culebras, Jesús M ^b   González Gallego, Javier ^b  

^a HOSPITAL DE LEÓN   (Spain)

^b NONE

Author keywords

antipyrine; cytochrome P450; liver; nutrition; oxidative metabolism

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CARDIAC AGENT; CYTOCHROME P450; DRUG; DRUG METABOLIZING ENZYME; ESTROGEN; GASTROINTESTINAL AGENT; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID; ORAL CONTRACEPTIVE AGENT; PHENAZONE; STEROID;

AEROBIC METABOLISM; DRUG METABOLISM; LIVER DISEASE; LIVER METABOLISM; LIVER MICROSOME; NUTRITION; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN RESTRICTION; REVIEW; TOTAL PARENTERAL NUTRITION;

ANIMALIA;

EID: 0030174931     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(96)00101-3     Document Type: Review

References (76)

1. Watkins PB. Role of cytochromes P-450 in drug metabolism and hepatotoxicity. Semin Liver Dis 1990;10:235
2. Ziegler DM. Detoxication: oxidation and reduction. In: Arias IM, Boyer JL, Fausto N, et al., eds. The liver: biology and pathobiology. New York: Raven Press, 1994:415
3. Shimada T, Iwasaki M, Martin MV, et al. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by human response in Salmonella typhimurium TA 1535/PSK1002. Cancer Res 1989;49:3218
4. Vestal RE, Norris AH, Tobin JD, et al. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clin Pharmacol Ther 1975;18:425
5. Vessell ES. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clin Pharmacol Ther 1979;26:275
6. Poulsen HE, Loft S. Antipyrine as a model drug to study hepatic drug-metabolizing capacity. J Hepatol 1988;6:374
7. Alvares AP, Anderson KE, Conney AH, et al. Interaction between nutritional factors and drug biotransformations in man. Proc Natl Acad Sci USA 1976;73:2501
8. Orioli S, Bandinelli I, Binardi A, et al. Hepatic antipyrine metabolism in athletes. J Sports Med 1990;30:261
9. Pessayre D, Allemand H, Benoist C, et al. Effect of surgery under general anaesthesia on antipyrine clearance. Br J Clin Pharmacol 1978;6:505
10. Waite NM, Rybak MJ, Krakovsky DJ, et al. Influence of subject age on the inhibition of oxidative metabolism by ciproftoxacin. Antimicrob Agents Chemother 1991;35:130
11. Sakaue H, Akamatsu K, Hirabayashi Y, et al. Effects of prolonged oral cimetidine, ranetidine, and famotidine therapy on antipyrine elimination. Clin Ther 1987;9:602
12. Williams SJ, Farrell GC. Inhibition of antipyrine metabolism by interferon. Br J Clin Pharmacol 1986;22:610
13. Massoomi F, Savage J, Destache CJ. Omeprazole: a comprehensive review. Pharmacotherapy 1993; 13:46
14. St Peter JV, Awni WN. Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites. Clin Pharmacokinet 1991;20:50
15. George J, Murray M, Byth K, et al. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995;21:120
16. Vestal RE, Wood AJJ. Influence of age and smoking on drug kinetics in man, studies using model compounds. Clin Pharmacokinet 1980;5:309
17. Greenblatt DJ, Divoll M, Abernethy DR, et al. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. J Pharmacol Exp Ther 1982;220:120
18. Bach B, Hansen JM, Kampmann JP, et al. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Clin Pharmacokinet 1981;6:389
19. Ptachcinski RJ, Carpenter BJ, Burckart GJ, et al. Effect of erythromycin on cyclosporine levels. N Engl J Med 1985;313:1416
20. Rowland M, Gupta SK. Cyclosporine-phenitoin interaction: reevaluation using metabolite data. Br J Clin Pharmacol 1987;24:329
21. Lele P, Peterson P, Yang S. Cyclosporine and tegretol, another drug interaction. Kidney Int 1985;27:344
22. Guengerich FP. Characterization of human microsomal cytochrome P-450 enzymes. Annu Rev Pharmacol Toxicol 1989;29:241
23. Jacqz E, Hall SD, Branch RA. Genetically determined polymorphisms in drug oxidation. Hepatology 1986; 6:1020
24. Whitlock JP. The regulation of cytochrome P-450 gene regulation. Annu Rev Pharmacol Toxicol 1986;26:333
25. Vesell ES. Genetic and environmental factors affecting drug disposition in man. Chn Pharmacol Ther 1977;22:659
26. Breimer DD. Interindividual variations in drug disposition. Clinical implications and methods of investigation. Clin Pharmacokinet 1983;8:371
27. Vuìtton D, Miguet JP, Camelot G, et al. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug- oxidizing enzyme activities in humans withot liver disease. Gastroenterology 1981;80:112
28. Drill VA. Hepatotoxic agents: mechanisms of action and dietary interaction. Pharmacol Rev 1952;4:1
29. Boyd EM, Krupa V. Protein-deficient diet and diuron toxicity. J Agric Food Chem 1970;18:1104
30. Krijnen CJ, Boyd EM. The influence of diets containing from 0 to 81 per cent of protein on tolerated doses of pesticides. Comp Gen Pharmacol 1971;22:373
31. Campbell TC, Hayes JR. Role of nutrition in the drug-metabolizing enzyme system. Pharmacol Rev 1971;26:171
32. Krishnawamy K, Naidu AN. Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine. Br Med J 1977;1:538
33. Narang RK, Metha S, Mathur VS. Pharmacokinetic study of antipyrine in malnourished children. Am J Clin Nutr 1977;30:79
34. Homeida M, Karrar ZA, Roberts JC. Drug metabolism in malnourished children: a study with antipyrine. Arch Dis Child 1979;54:299
35. Sánchez V, Newton DJ, Clark RG, et al. Drug metabolism in malnourished patients assessed by antipyrine clearance. The effect of parenteral feeding. Proc Nutr Soc 1982;41:118A
36. Tranvouez JL, Lerebours E, Chretien P, et al. Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation. Am J Clin Nutr 1985;41:1257
37. Mgbodile MUK, Campbell TC. Effect of protein deprivation of male weanling rats on the kinetics of hepatic rnicrosomal enzyme activity. J Nutr 1972;102:53
38. Hayes JR, Campbell TC. Effect of protein deficiency on the inducibility of the hepatic microsomal drug-metabolizing enzymes system. III. Effect of 3-methyl-cholanthrene induction on activity and binding kinetics. Biochem Pharmacol 1974;23:1721
39. Campbell TC. Nutrition and drug-metabolizing enzymes. Clin Pharmacol Ther 1977;22:699
40. Pantuck EJ, Pantuck CB, Weissman CH, et al. Stimulation of oxidative drug metabolism by parenteral refeeding of nutritionally depleted patients. Gastroenterology 1985;89:241
41. Jorquera F, Almar MM, González Sastre, et al. Cambios en el metabolismo oxidativo hepático en los ancianos según el estado nutricional. Nutr Hosp 1995;10:43S
42. Caraco Y, Zylber-Katz E, Berry EM, et al. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism. Eur J Clin Pharmacol 1995;47:525
43. Dixon RL, Shultice RW, Fouts JR. Factors affecting drug metabolism by liver microsomes. IV. Starvation. Proc Soc Exp Biol Med 1960;103:333
44. Zannoni VG, Sato PH. Effects of ascorbic acid on microsomal drug metabolism. N Y Acad Sci 1975;258:119
45. Pantuck EJ, Hsiao KC, Loub WD, et al. Stimulatory effect of vegetables on intestinal drug metabolism in the rat. J Pharmacol Exp Ther 1976;198:278
46. Campbell TC, Hayes JR. The effect of quantity and quality of dietary protein on drug metabolism. Fed Proc 1976;35:2470
47. Wade AE, Norred WP. Effect of dietary lipid on drug-metabolizing enzymes. Fed Proc 1976;35:2476
48. Kappas A, Anderson KE, Conney AH, et al. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin Pharmacol Ther 1976;20:643
49. Anderson KE, Conney AH, Kappas A. Nutrition and oxidative drug metabolism in man: Relative influence of dietary lipids, carbohydrate, and protein. Clin Pharmacol Ther 1979;26:493
50. Feldman CH, Hutchinson VE, Pippenger CE, et al. Effect of dietary protein and carbohydrate on theophylline metabolism in children. Pediatrics 1980;66:956
51. Pantuck EJ, Pantuck CB, Garland WA, et al. Stimulatory effect of brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther 1979;25:88
52. Kappas A, Alvares AP, Anderson KE, et al. Effect of charcoalbroiled beef on antipyrine and theophylline metabolism. Clin Pharmacol Ther 1978;23:445
53. Houston JB. Effect of vitamin C supplement on antipyrine disposi-tion in man. Br J Clin Pharmacol 1977;4:236
54. Blanchard J, Achari R, Harrison GG, et al. The influence of vitamin C on antipyrine pharmacokinetics in elderly men. Biopharm Drug Dispos 1984;5:43
55. Smithard DJ, Langman MJS. The effect of vitamin supplementation upon antipyrine metabolism in the elderly. Br J Clin Pharmacol 1978;5:181
56. Garcia-Vielba J, Ribas-Ariño T, Garcia-Díez F, et al. Estudio histopatológico de las alteraciones hepáticas inducidas por la nutritión parenteral en la rata. Nutr Hosp 1992;6:288
57. Balisteri WF, Bove KE. Hepatobilary consequences of parenteral alimentation. In: Popper H, Schaffner F, eds. Progress in liver diseases. Philadelphia: WB Saunders, 1990:567
58. Quigley EMM, Marsh MN, Shaffer JL, et al. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286
59. Jorquera F, Villares C, Culebras JM. Nutrición artificial en las hepatopatías. In: Culebras JM, González J, García A, eds. Nutrición por la via enteral. Madrid: Grupo Aula Médica, 1994:187
60. Earl-Salotti GL, Charland SL. The effect of parenteral nutrition on hepatic cytochrome P-450. J Parent Ent Nutr 1994;18:458
61. Knodell RG, Steele NM, Cerra FB. Effects of parenteral and enteral hyperalimentation on hepatic drug metabolism in the rat. J Pharmacol Exp Ther 1984;229:589
62. Knodell RG, Wood DG, Guengerich FP. Selective alteration of constitutive hepatic cytochrome P-450 enzymes in the rat during parenteral hyperalimentation. Biochem Pharmacol 1989;38:3341
63. Ross LH, Griffeth L, Hall RI. Hepatotoxic effects of parenteral nutrition upon the in vivo pharmacokinetics of antipyrine. Surg Forum 1983;34:34
64. Ross LH, Griffeth L, Hall RI. Elimination of hepatotoxic effects of parenteral nutrition using fat-carbohydrate mixture. Surg Forum 1984;35:97
65. Knodell RG, Whitmer DI, Holman RT. Influence of hyperalimentation on rat hepatic microsomal fluidity and function. Gastroenterology 1990;98:1320
66. Pantuck EJ, Pantuck CB, Weissman C, et al. Effects of parenteral nutritional regimens on oxidative drug metabolism. Anesthesiology 1984; 60:534
67. Pantuck JP, Weissman CH, Pantuck CB, et al. Effects of parenteral amino acid nutritional regimens on oxidative and conjugative drug metabolism. Anesth Analg 1989;69:727
68. Burgess P, Hall RI, Bateman DN, et al. The effect of total parenteral nutrition on hepatic drug oxidation. J Parent Ent Nutr 1987;11:540
69. Ross LH, Jurkovitch G, Rauchman E. Hepatotoxic effects of parenteral nutrition. An investigation of rat microsomal enzymes. JPEN 1982;6:579
70. Pomposelli JJ, Moldawer LL, Palombo JD. Short-term administration of parenteral glucose-lipid mixtures improves protein kinetics in portocaval shunted rats. Gastroenterology 1986;91:305
71. Baldermann H, Wicklmayr M, Rett K. Changes of hepatic morphology during parenteral nutrition with emulsions containing LCT or MCT/LCT quantified by ultrasound. JPEN 1991;15:601
72. Culebras JM, García de Lorenzo A, Zarazaga A, et al. EUROPAN: European project for the study of hypocaloric peripheral nutrition in surgical patients. J Clin Nutr Gastroenterol 1990;5:99
73. Jorquera F, Almar M, Martínez C, et al. Antipyrine clearance in surgical patients maintained on hypocaloric peripheral parenteral nutrition. JPEN 1994;18:544
74. Rouer E, Dansette P, Beaune P. Membrane fluidity and drug metabolism in liver microsomes of lean, ob/ob, and db/db mice. Biochem Biophys Res Commun 1980;95:41
75. Japitulnik J, Well E, Rabinowitz R. Fetal and adult human liver differ markedly in the fluidity and lipid composition of their microsomal membranes. Hepatology 1987;7:55
76. Archakov AI, Borodin EA, Drobetsov GE. The influence of cholesterol incorporation and removal on lipid-bilayer viscosity and electron transport in rat liver microsomes. Eur J Biochem 1983;134:89